<?xml version="1.0" encoding="UTF-8"?>
<ref id="B28-vaccines-08-00197">
 <label>28.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lee</surname>
    <given-names>Y.-T.</given-names>
   </name>
   <name>
    <surname>Ko</surname>
    <given-names>E.-J.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>K.-H.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>M.-C.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>Y.-N.</given-names>
   </name>
   <name>
    <surname>Kang</surname>
    <given-names>S.-M.</given-names>
   </name>
  </person-group>
  <article-title>Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses</article-title>
  <source>PLoS ONE</source>
  <year>2018</year>
  <volume>13</volume>
  <elocation-id>e0190868</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0190868</pub-id>
  <?supplied-pmid 29324805?>
  <pub-id pub-id-type="pmid">29324805</pub-id>
 </element-citation>
</ref>
